
FDA Approves First Drug That Can Delay Onset of Type 1 Diabetes
For Immediate Release: November 17, 2022 Today, the U.S. Food and Drug Administration approved Tzield (teplizumab-mzwv) injection to delay the onset of stage 3 type 1 diabetes in adults and pediatric patients 8 years and older who currently have stage 2 …